ID   SCCRDEB5
AC   CVCL_G306
DR   Wikidata; Q54952395
RX   PubMed=21602893;
DI   NCIt; C84691; Epidermolysis bullosa dystrophica
DI   NCIt; C4819; Skin squamous cell carcinoma
DI   ORDO; Orphanet_303; Dystrophic epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
RX   PubMed=21602893; DOI=10.1038/onc.2011.180; PMCID=PMC3219832;
RA   Watt, Stephen A.
RA   Pourreyron, Celine
RA   Purdie, Karin J.
RA   Hogan, Chris
RA   Killick-Cole, Clare L.
RA   Foster, Nicola
RA   Pratt, Norman
RA   Bourdon, Jean-Christophe
RA   Appleyard, Maria Viginia C.L.
RA   Murray, Kevin
RA   Thompson, Alastair M.
RA   Mao, Xin
RA   Mein, Charles A.
RA   Bruckner-Tuderman, Leena Kaarina
RA   Evans, Alan T.
RA   McGrath, John Alexander
RA   Proby, Charlotte Mary
RA   Foerster, John
RA   Leigh, Irene May
RA   South, Andrew P.
RT   "Integrative mRNA profiling comparing cultured primary cells with
RT   clinical samples reveals PLK1 and C20orf20 as therapeutic targets in
RT   cutaneous squamous cell carcinoma.";
RL   Oncogene 30:4666-4677(2011).
//